Entering text into the input field will update the search result below

Rosetta Genomics (NASDAQ:ROSG-OLD) jumps 10.6% premarket after saying the peer-reviewed journal...

Jun. 06, 2013 9:04 AM ETRosetta Genomics Ltd. (ROSG-OLD) StockROSG-OLDBy: Colin Lokey, SA News Editor

Rosetta Genomics (NASDAQ:ROSG-OLD) jumps 10.6% premarket after saying the peer-reviewed journal Molecular Cancer, has accepted a manuscript outlining the ability of the company's miRview test (I, II) to accurately "identify the tumor of origin." In short, the test's predictions agreed with the final diagnosis in 92% of the 84 patients from which samples were taken. (PR)

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ROSG-OLD--
Rosetta Genomics Ltd.